WallStreetZenWallStreetZen

NASDAQ: LXRX
Lexicon Pharmaceuticals Inc Earnings & Revenue

LXRX past revenue growth

How has LXRX's revenue growth performed historically?
Company
1,734.13%
Industry
83.69%
Market
19.3%
LXRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LXRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LXRX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LXRX earnings and revenue history

Current Revenue
$2.3M
Current Earnings
-$193.6M
Current Profit Margin
-8,376.5%

LXRX Return on Equity

Current Company
-109.4%
Current Industry
16.9%
Current Market
28.2%
LXRX's Return on Equity (-109.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LXRX announces earnings.

LXRX Return on Assets

Current Company
-62.5%
Current Industry
3.2%
LXRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LXRX Return on Capital Employed

Current Company
-45.03%
Current Industry
-42.5%
LXRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LXRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LXRX$2.31M-$176.77M-$193.58M-45.27%N/A
TERN$0.00-$89.88M-$91.06M-100.00%N/A
IGMS$2.11M-$222.04M-$236.92M+32.31%N/A
SLRN$0.00-$239.81M-$240.16MN/AN/A
URGN$84.30M-$85.13M-$104.32M+164.84%N/A

LXRX earnings dates

Next earnings date
Aug 1, 2024

Lexicon Pharmaceuticals Earnings & Revenue FAQ

What were LXRX's earnings last quarter?

On Invalid Date, Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q1 2024 earnings per share (EPS) of -$0.20, up 17.65% year over year. Total Lexicon Pharmaceuticals earnings for the quarter were -$48.40 million. In the same quarter last year, Lexicon Pharmaceuticals's earnings per share (EPS) was -$0.17.

If you're new to stock investing, here's how to buy Lexicon Pharmaceuticals stock.

What was LXRX's earnings growth in the past year?

As of Q2 2024, Lexicon Pharmaceuticals's earnings has grown year over year. Lexicon Pharmaceuticals's earnings in the past year totalled -$193.58 million.

What is LXRX's earnings date?

Lexicon Pharmaceuticals's earnings date is Invalid Date. Add LXRX to your watchlist to be reminded of LXRX's next earnings announcement.

What was LXRX's revenue last quarter?

On Invalid Date, Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q1 2024 revenue of $1.13 million up 4,608.33% year over year. In the same quarter last year, Lexicon Pharmaceuticals's revenue was $24.00 thousand.

What was LXRX's revenue growth in the past year?

As of Q2 2024, Lexicon Pharmaceuticals's revenue has grown 1,734.13% year over year. This is 1,650.44 percentage points higher than the US Biotechnology industry revenue growth rate of 83.69%. Lexicon Pharmaceuticals's revenue in the past year totalled $2.31 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.